Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
PRSS56 encodes a protein that contains a peptidase S1 domain and possesses trypsin-like serine protease activity. Additionally we are shipping and many more products for this protein.
Showing 3 out of 3 products:
variations in PRSS56 were evaluated in patients with either primary angle-closure glaucoma (PACG) or high hyperopia.
Idenification of a founder mutation in the PRSS56 gene in Tunisian families with posterior microphthalmia and nanophthalmia.
Corneal diameter decreases with decreasing axial length, suggesting posterior microphthalmos and nanophthalmos represent a spectrum of high hyperopia rather than distinct phenotypes. In the Saudi population PRSS56 mutations are the major cause.
PRSS56 is a good candidate for the causal gene for nanophthalmos in a Mexican-Canadian family cohort.
Together, these data suggest that alterations of this serine protease (show F2 Antibodies) may contribute to a spectrum of human ocular conditions including reduced ocular size and ACG (show DOCK11 Antibodies).
Three different mutations in PRSS56, were detected in microphthalmos patients of the Faroese families.
This gene encodes a protein that contains a peptidase S1 domain and possesses trypsin-like serine protease activity. The encoded protein may play a role in eye development, and mutations in this gene are a cause of autosomal recessive posterior microphthalmos.
putative serine protease 56
, serine protease 56